CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES:
Net loss	$ (8,207)	$ (14,283)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation	19,800	20,183
Amortization, including accretion and write-off of deferred financing costs	6,077	6,187
Deferred income taxes	(2,732)	(2,834)
Loss of equity method investee	641	424
Gain on sale of fixed assets	(861)	(95)
Share-based compensation expense	2,272	4,421
Excess tax deficiency related to share-based compensation expense	74	266
Gain on settlement of net investment hedge	0	(3,716)
Changes in operating assets and liabilities:
Accounts receivable, net	(21,335)	(28,333)
Inventories, net	(33,651)	(24,333)
Prepaid expenses and other assets	7,473	(15,510)
Accounts payable	23,322	18,366
Accrued expenses and other liabilities	1,459	15,119
Net cash used for operating activities	(5,668)	(24,138)
INVESTING ACTIVITIES:
Capital expenditures, including intangibles	(28,584)	(22,877)
Proceeds from sale of fixed assets	1,841	95
Proceeds from settlement of net investment hedge	0	3,820
Investment in venture capital fund, net	(200)	(700)
Net cash used for investing activities	(26,943)	(19,662)
FINANCING ACTIVITIES:
Revolving credit facility borrowings	81,365	21,817
Revolving credit facility payments	(64,568)	(18,000)
Proceeds from issuance of debt	27,579	30,513
Repayments of debt	(27,145)	(32,789)
Earn-out consideration cash payment	0	(6,276)
Repurchase of Common Shares to satisfy employee tax withholding	(1,697)	(760)
Net cash provided by (used for) financing activities	15,534	(5,495)
Effect of exchange rate changes on cash and cash equivalents	(963)	(3,915)
Net change in cash and cash equivalents	(18,040)	(53,210)
Cash and cash equivalents at beginning of period	54,798	85,547
Cash and cash equivalents at end of period	36,758	32,337
Supplemental disclosure of cash flow information:
Cash paid for interest, net	9,248	4,992
Cash paid for income taxes, net	$ 8,453	$ 5,808

The aggregate expense charged against earnings to allocate the cost of intangible assets including deferred financing costs (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Also included in this amount is the accretion of the debt discount and the deferred financing costs which are a component of interest expense representing the periodic charge against earnings to reflect amortization of debt discounts and deferred financing costs over the life of the related debt instrument. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.